4.6 Article

Cutting Edge: Impaired MHC Class I Expression in Mice Deficient for Nlrc5/Class I Transactivator

Journal

JOURNAL OF IMMUNOLOGY
Volume 189, Issue 2, Pages 516-520

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1200064

Keywords

-

Categories

Funding

  1. National Institutes of Health
  2. Crohn's and Colitis Foundation of America
  3. Cancer Research Institute
  4. Claudia Adams Barr Award
  5. European Molecular Biology Organization Long-Term fellowship
  6. Crohn's Colitis Foundation of America fellowship

Ask authors/readers for more resources

MHC class I and class II are crucial for the adaptive immune system. Although regulation of MHC class II expression by CIITA has long been recognized, the mechanism of MHC class I transactivation has been largely unknown until the recent discovery of NLRC5/class I transactivator. In this study, we show using Nlrc5-deficient mice that NLRC5 is required for both constitutive and inducible MHC class I expression. Loss of Nlrc5 resulted in severe reduction in the expression of MHC class I and related genes such as beta(2)-microglobulin, Tap1, or Lmp2, but did not affect MHC class II levels. IFN-gamma stimulation could not overcome the impaired MHC class I expression in Nlrc5-deficient cells. Upon infection with Listeria monocyogenes, Nlrc5-deficient mice displayed impaired CD8(+) T cell activation, accompanied with increased bacterial loads. These findings illustrate critical roles of NLRC5/class I transactivator in MHC class I gene regulation and host defense by CD8(+) T cell responses. The Journal of Immunology, 2012, 189: 516-520.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available